癌症中的微生物群:次要参与者还是主角?
Ana María Gómez García1,2,3, Francisco López Muñoz2,3, Eduardo García-Rico2,3,4
1Internal Medicine Unit, Hospital Universitario HM Madrid, 28015 Madrid, Spain.
Current issues in molecular biology
|August 28, 2024
概括
人的肠道微生物群,一个重要的代谢器官,影响消化,免疫力和癌症的发展. 操纵这种微生物群可能为癌症治疗提供新的治疗策略.
科学领域:
- 微生物学 微生物学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 人体与肠道微生物群保持着共生关系,这对许多生理功能至关重要.
- 这种微生物群充当代谢器官,影响消化,新陈代谢,免疫发育和防御.
- 新兴研究强调了微生物群在各种病理,特别是癌症中的重要作用.
研究的目的:
- 探索肠道微生物群与癌症之间的复杂关系.
- 研究微生物群对瘤发生,瘤进展和对癌症治疗的反应的影响.
- 检查肠道微生物群与抗瘤药物的疗效和副作用之间的相互作用.
主要方法:
- 审查关于肠道微生物群及其在癌症中的作用的当前科学文献.
- 对研究微生物群对瘤发育的系统性影响的研究进行分析.
- 检查微生物群与药物相互作用的研究,特别是与抗瘤剂的研究.
主要成果:
- 肠道失生症与癌症的发病,进展和治疗反应有关.
- 微生物群对瘤发育具有局部和全身的影响.
- 肠道微生物群显著调节癌症药物的活性,副作用和治疗疗效.
结论:
- 肠道微生物群是癌症发展和治疗的关键参与者.
- 针对微生物群的疗法显示出作为增强瘤治疗的辅助策略的潜力.
- 进一步的研究是有必要的,以探索治疗操作的微生物群的癌症管理.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
The Roles of Bacteria and Fungi in Plant Nutrition
35.1K
Plants have the impressive ability to create their own food through photosynthesis. However, plants often require assistance from organisms in the soil to acquire the nutrients they need to function correctly. Both bacteria and fungi have evolved symbiotic relationships with plants that help the species to thrive in a wide variety of environments.
35.1K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


